Related Experiment Video
Updated: May 19, 2026
12:19
Multi-Scale Modification of Metallic Implants With Pore Gradients, Polyelectrolytes and Their Indirect Monitoring In vivo
Published on: July 1, 2013
Genetic and immunological markers predict titanium implant failure: a retrospective study
E Jacobi-Gresser1, K Huesker, S Schütt
1Department of Immunology, Laboratory Center Berlin, Berlin, Germany.
International Journal of Oral and Maxillofacial Surgery
|August 29, 2012
Summary
Predicting titanium implant failure is possible using genetic markers and cytokine release assays. Higher levels of TNF-α and IL-1β, along with specific gene variants, indicate an increased risk of implant loss.
Area of Science:
- Biomaterials Science
- Immunogenetics
- Oral Implantology
Background:
- Titanium implant failure remains a significant clinical challenge.
- Predictive markers for implant success are crucial for patient outcomes.
- Genetic predispositions and inflammatory responses may influence implant survival.
Purpose of the Study:
- To evaluate diagnostic markers for predicting titanium implant failure.
- To investigate the association between specific gene polymorphisms (IL1A, IL1B, IL1RN, TNFA) and implant outcomes.
- To assess the utility of in vitro cytokine release assays and lymphocyte transformation tests in predicting implant failure.
Main Methods:
- Retrospective analysis of 109 subjects with titanium implants.
- Genotyping for IL1A, IL1B, IL1RN, and TNFA polymorphisms.
- In vitro assessment of Interleukin-1 beta (IL-1β) and Tumor Necrosis Factor-alpha (TNF-α) release upon titanium stimulation.
- Lymphocyte transformation tests were performed during treatment.
Main Results:
- Significantly higher TNF-α and IL-1β release in patients with implant loss compared to controls.
- Increased prevalence of minor alleles for IL1A, IL1B, and TNFA polymorphisms in the implant failure group.
- Positive cytokine release assay scores and a higher number of risk genotypes were independently associated with titanium implant failure.
Conclusions:
- IL-1/IL1RN/TNFA genotyping can serve as prognostic markers for titanium implant outcomes.
- Cytokine release assay scores offer valuable prognostic information for implant success.
- These markers may enable individualized risk assessment for titanium implant procedures.
